Home / Products / Genome-edited Cells / DISC1 Knockout U-251MG Cell Line

DISC1 Knockout U-251MG Cell Line

Cat. No. ARG43816
Product Type:

In Stock Cell Lines

Species:

Homo sapiens (Human)

Tissue Source:

Brain (parietal lobe)

Growth Properties:

Adherent

In stock
Request a Quote

Short Description

The DISC1 Knockout U-251MG Cell Line is a CRISPR/Cas9-edited human glioblastoma cell line with targeted disruption of the DISC1 gene. Derived from the U-251MG line, it provides a loss-of-function model for studying this critical scaffold protein in a mesenchymal-like glioblastoma background. DISC1 interacts with partners such as NDE1, GSK3??, and PDE4B, regulating pathways including Wnt/GSK3?? and cAMP/PKA. This knockout model enables investigation of DISC1's role in migration, invasion, and signaling, with applications in neurobiology and cancer research, including kinase inhibitor screening and pathway analysis.

Product Details
Cell Engineering
Immortalization
Culture Conditions
Quality Control
Disclaimer

Product Details

Species:
Homo sapiens (Human)
Tissue Source:
Brain (parietal lobe)
Disease:
Astrocytoma
Growth Properties:
Adherent
Donor Age:
75 years

Cell Engineering Information

Gene Name:
DISC1
Gene Identifier:
NCBI Gene ID 27185

Immortalization Information

Culture Conditions

Temperature:
37°C
Atmosphere:
5% CO₂

Quality Control

Sterility testing:
The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

Disclaimer

Intended Use:
This product is intended for laboratory in vitro use only. It is not intended for diagnostic, therapeutic, or clinical applications.
Disclaimer:
Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability.
Usage:
By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use. This product is provided "AS IS".

Description

The DISC1 Knockout U-251MG Cell Line is a CRISPR/Cas9-edited cell line derived from the human U-251MG glioblastoma line, featuring targeted disruption of the DISC1 gene. This knockout model enables stable loss-of-function studies of the DISC1 scaffold protein, circumventing the limitations of transient gene silencing. The cell line is suitable for investigating DISC1-dependent signaling and cellular phenotypes, providing a robust platform for both mechanistic and translational research.

U-251MG is a widely used human glioblastoma cell line originally established from a grade IV astrocytoma. It exhibits a mesenchymal-like phenotype with high invasive and tumorigenic capacity, making it a relevant model for glioblastoma multiforme. The line retains key oncogenic signaling alterations, including dysregulation of growth factor and cytoskeletal pathways, offering a permissive background for studying the contributions of neurodevelopmental proteins to glioblastoma progression.

DISC1 encodes a multifunctional scaffold protein that assembles signaling complexes regulating neurodevelopment. It receives signals from upstream factors such as BDNF, Reelin, GSK3??, AKT, and PKA, and coordinates downstream effectors including NDE1/NDEL1, LIS1, PDE4, and ERK1/2. DISC1 directly interacts with FEZ1, ATF4, MAP1A, TNIK, and Kalirin-7, modulating pathways like Wnt/GSK3??, cAMP/PKA, and PI3K/AKT. Through these interactions, DISC1 controls processes such as neuronal migration and neurite outgrowth, and its disruption alters phosphorylation dynamics and transcriptional programs.

Loss of DISC1 in U-251MG cells disrupts the integration of neurodevelopmental signaling nodes that may intersect with glioblastoma pathology. Since DISC1 scaffolds interactions between AKT, GSK3??, and NDE1/LIS1 complexes, its knockout can perturb cytoskeletal organization, cell migration, and invasion??traits critical to glioma aggressiveness. This model therefore allows dissection of how scaffold proteins influence mesenchymal-like tumor cell behavior and may uncover signaling dependencies that are amenable to pharmacological intervention.

Researchers can employ this knockout cell line for diverse applications, including Western blot analysis of DISC1 and phospho-proteins (e.g., phospho-AKT, GSK3??), RT-qPCR for gene expression changes, and immunofluorescence to visualize interacting partners. Functional assays like Boyden chamber migration, invasion, and MTT proliferation can be conducted to assess phenotypic consequences. The model is suited for kinase inhibitor screening, functional complementation, and co-immunoprecipitation of DISC1 complexes. It also serves as a tool for psychiatric disease mechanism studies and transcriptomic analysis by RNA-seq. For additional details, please contact Ascent Research.